HER2 Support Group Forums - View Single Post - Evaluating the Efficacy of chemo in postmeno ER+ pts

Rich66 · 04-17-2011, 12:35 PM

[P5-10-08] Evaluating the Efficacy of Current Clinical Practice of Adjuvant Chemotherapy in Post-Menopausal Women with One to Three Positive Auxiliary Nodes and Estrogen and/or Progesterone Positive Early Stage Breast Cancer.

Conclusion: The treatment standard of adjuvant chemotherapy in addition to endocrine therapy for the majority of women with 1-3 LN+ and ER+/PR+ ESBC was not found to be associated with incremental survival benefit in comparison with previous standards. Our results suggest that a large number of patients with 1-3 LN+ and ER+/PR+ ESBC may not gain benefit from adding chemotherapy to endocrine therapy.

04-17-2011, 12:35 PM	#2
Rich66 Senior Member Join Date: Feb 2008 Location: South East Wisconsin Posts: 3,431	Re: Evaluating the Efficacy of chemo in postmeno ER+ pts [P5-10-08] Evaluating the Efficacy of Current Clinical Practice of Adjuvant Chemotherapy in Post-Menopausal Women with One to Three Positive Auxiliary Nodes and Estrogen and/or Progesterone Positive Early Stage Breast Cancer. Conclusion: The treatment standard of adjuvant chemotherapy in addition to endocrine therapy for the majority of women with 1-3 LN+ and ER+/PR+ ESBC was not found to be associated with incremental survival benefit in comparison with previous standards. Our results suggest that a large number of patients with 1-3 LN+ and ER+/PR+ ESBC may not gain benefit from adding chemotherapy to endocrine therapy. __________________ Mom's treatment history (link)